Global Monoclonal antibodies (mAbs) Biosimilars Market Insights and Forecast to 2031

Report ID: 1666043 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Erythropoietin (EPO)
        1.2.3 Human Growth Hormone (HGH)
        1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
        1.2.5 Monoclonal Antibody (mAb)
        1.2.6 Insulin
        1.2.7 Interferon (IFN)
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anti-Cancer
        1.3.3 Anti-Inflammatory/Autoimmune
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Perspective (2017-2028)
    2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Trends by Region
        2.2.1 Monoclonal antibodies (mAbs) Biosimilars Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Region (2017-2022)
        2.2.3 Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2023-2028)
    2.3 Monoclonal antibodies (mAbs) Biosimilars Market Dynamics
        2.3.1 Monoclonal antibodies (mAbs) Biosimilars Industry Trends
        2.3.2 Monoclonal antibodies (mAbs) Biosimilars Market Drivers
        2.3.3 Monoclonal antibodies (mAbs) Biosimilars Market Challenges
        2.3.4 Monoclonal antibodies (mAbs) Biosimilars Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue
        3.1.1 Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Revenue (2017-2022)
        3.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Players (2017-2022)
    3.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Monoclonal antibodies (mAbs) Biosimilars Revenue
    3.4 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio
        3.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2021
    3.5 Monoclonal antibodies (mAbs) Biosimilars Key Players Head office and Area Served
    3.6 Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
    3.7 Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Type
    4.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Type (2017-2022)
    4.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2023-2028)
5 Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application
    5.1 Global Monoclonal antibodies (mAbs) Biosimilars Historic Market Size by Application (2017-2022)
    5.2 Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size (2017-2028)
    6.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
        6.2.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022)
        6.2.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028)
        6.2.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2017-2028)
    6.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
        6.3.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022)
        6.3.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028)
        6.3.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2017-2028)
    6.4 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
        6.4.1 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022)
        6.4.2 North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size (2017-2028)
    7.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
        7.2.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022)
        7.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028)
        7.2.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2017-2028)
    7.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
        7.3.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022)
        7.3.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028)
        7.3.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2017-2028)
    7.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
        7.4.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022)
        7.4.2 Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size (2017-2028)
    8.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
        8.2.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2017-2028)
    8.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
        8.3.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2017-2028)
    8.4 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region
        8.4.1 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size (2017-2028)
    9.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
        9.2.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022)
        9.2.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028)
        9.2.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2017-2028)
    9.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
        9.3.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022)
        9.3.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028)
        9.3.3 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2017-2028)
    9.4 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
        9.4.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022)
        9.4.2 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size (2017-2028)
    10.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type
        10.2.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Type (2017-2028)
    10.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application
        10.3.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2017-2028)
    10.4 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country
        10.4.1 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Biocon
        11.1.1 Biocon Company Details
        11.1.2 Biocon Business Overview
        11.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.1.4 Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.1.5 Biocon Recent Developments
    11.2 Celltrion
        11.2.1 Celltrion Company Details
        11.2.2 Celltrion Business Overview
        11.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.2.4 Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.2.5 Celltrion Recent Developments
    11.3 Dr. Reddy's Laboratories
        11.3.1 Dr. Reddy's Laboratories Company Details
        11.3.2 Dr. Reddy's Laboratories Business Overview
        11.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.3.4 Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.3.5 Dr. Reddy's Laboratories Recent Developments
    11.4 Hospira
        11.4.1 Hospira Company Details
        11.4.2 Hospira Business Overview
        11.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.4.4 Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.4.5 Hospira Recent Developments
    11.5 3SBio
        11.5.1 3SBio Company Details
        11.5.2 3SBio Business Overview
        11.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.5.4 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.5.5 3SBio Recent Developments
    11.6 Accord Healthcare
        11.6.1 Accord Healthcare Company Details
        11.6.2 Accord Healthcare Business Overview
        11.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.6.4 Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.6.5 Accord Healthcare Recent Developments
    11.7 AET Biotech
        11.7.1 AET Biotech Company Details
        11.7.2 AET Biotech Business Overview
        11.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.7.4 AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.7.5 AET Biotech Recent Developments
    11.8 Allergan
        11.8.1 Allergan Company Details
        11.8.2 Allergan Business Overview
        11.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.8.4 Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.8.5 Allergan Recent Developments
    11.9 Amega Biotech
        11.9.1 Amega Biotech Company Details
        11.9.2 Amega Biotech Business Overview
        11.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Introduction
        11.9.4 Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
        11.9.5 Amega Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Erythropoietin (EPO)
    Table 3. Key Players of Human Growth Hormone (HGH)
    Table 4. Key Players of Granulocyte- Colony Stimulating Factor (G-CSF)
    Table 5. Key Players of Monoclonal Antibody (mAb)
    Table 6. Key Players of Insulin
    Table 7. Key Players of Interferon (IFN)
    Table 8. Key Players of Others
    Table 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2017-2022)
    Table 13. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region (2023-2028)
    Table 15. Monoclonal antibodies (mAbs) Biosimilars Market Trends
    Table 16. Monoclonal antibodies (mAbs) Biosimilars Market Drivers
    Table 17. Monoclonal antibodies (mAbs) Biosimilars Market Challenges
    Table 18. Monoclonal antibodies (mAbs) Biosimilars Market Restraints
    Table 19. Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Players (2017-2022)
    Table 21. Global Top Monoclonal antibodies (mAbs) Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2021)
    Table 22. Ranking of Global Top Monoclonal antibodies (mAbs) Biosimilars Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Monoclonal antibodies (mAbs) Biosimilars Product Solution and Service
    Table 26. Date of Enter into Monoclonal antibodies (mAbs) Biosimilars Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2017-2022)
    Table 30. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2023-2028)
    Table 32. Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2017-2022)
    Table 34. Global Monoclonal antibodies (mAbs) Biosimilars Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Application (2023-2028)
    Table 36. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Biocon Company Details
    Table 67. Biocon Business Overview
    Table 68. Biocon Monoclonal antibodies (mAbs) Biosimilars Product
    Table 69. Biocon Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 70. Biocon Recent Developments
    Table 71. Celltrion Company Details
    Table 72. Celltrion Business Overview
    Table 73. Celltrion Monoclonal antibodies (mAbs) Biosimilars Product
    Table 74. Celltrion Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 75. Celltrion Recent Developments
    Table 76. Dr. Reddy's Laboratories Company Details
    Table 77. Dr. Reddy's Laboratories Business Overview
    Table 78. Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Product
    Table 79. Dr. Reddy's Laboratories Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 80. Dr. Reddy's Laboratories Recent Developments
    Table 81. Hospira Company Details
    Table 82. Hospira Business Overview
    Table 83. Hospira Monoclonal antibodies (mAbs) Biosimilars Product
    Table 84. Hospira Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 85. Hospira Recent Developments
    Table 86. 3SBio Company Details
    Table 87. 3SBio Business Overview
    Table 88. 3SBio Monoclonal antibodies (mAbs) Biosimilars Product
    Table 89. 3SBio Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 90. 3SBio Recent Developments
    Table 91. Accord Healthcare Company Details
    Table 92. Accord Healthcare Business Overview
    Table 93. Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Product
    Table 94. Accord Healthcare Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 95. Accord Healthcare Recent Developments
    Table 96. AET Biotech Company Details
    Table 97. AET Biotech Business Overview
    Table 98. AET Biotech Monoclonal antibodies (mAbs) Biosimilars Product
    Table 99. AET Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 100. AET Biotech Recent Developments
    Table 101. Allergan Company Details
    Table 102. Allergan Business Overview
    Table 103. Allergan Monoclonal antibodies (mAbs) Biosimilars Product
    Table 104. Allergan Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 105. Allergan Recent Developments
    Table 106. Amega Biotech Company Details
    Table 107. Amega Biotech Business Overview
    Table 108. Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Product
    Table 109. Amega Biotech Revenue in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022) & (US$ Million)
    Table 110. Amega Biotech Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Type: 2021 VS 2028
    Figure 2. Erythropoietin (EPO) Features
    Figure 3. Human Growth Hormone (HGH) Features
    Figure 4. Granulocyte- Colony Stimulating Factor (G-CSF) Features
    Figure 5. Monoclonal Antibody (mAb) Features
    Figure 6. Insulin Features
    Figure 7. Interferon (IFN) Features
    Figure 8. Others Features
    Figure 9. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Application: 2021 VS 2028
    Figure 10. Anti-Cancer Case Studies
    Figure 11. Anti-Inflammatory/Autoimmune Case Studies
    Figure 12. Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
    Figure 13. Global Monoclonal antibodies (mAbs) Biosimilars Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Monoclonal antibodies (mAbs) Biosimilars Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Region: 2021 VS 2028
    Figure 16. Global Monoclonal antibodies (mAbs) Biosimilars Market Share by Players in 2021
    Figure 17. Global Top Monoclonal antibodies (mAbs) Biosimilars Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal antibodies (mAbs) Biosimilars as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Monoclonal antibodies (mAbs) Biosimilars Revenue in 2021
    Figure 19. North America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Type (2017-2028)
    Figure 21. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Application (2017-2028)
    Figure 22. North America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Country (2017-2028)
    Figure 23. United States Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Country (2017-2028)
    Figure 29. Germany Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Region (2017-2028)
    Figure 39. China Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Country (2017-2028)
    Figure 49. Mexico Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Monoclonal antibodies (mAbs) Biosimilars Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Size Share by Country (2017-2028)
    Figure 55. Turkey Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Monoclonal antibodies (mAbs) Biosimilars Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Biocon Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 59. Celltrion Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 60. Dr. Reddy's Laboratories Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 61. Hospira Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 62. 3SBio Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 63. Accord Healthcare Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 64. AET Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 65. Allergan Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 66. Amega Biotech Revenue Growth Rate in Monoclonal antibodies (mAbs) Biosimilars Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Frequently Asked Questions
Monoclonal antibodies (mAbs) Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Monoclonal antibodies (mAbs) Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Monoclonal antibodies (mAbs) Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Macadamia

Macadamia market is segmented by Type and by Application. Players, stakeholders, and other partic ... Read More

Machine Translation

Machine Translation market is segmented by players, region (country), by Type and by Application. ... Read More